Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Evaluation of Sentinel Lymph Node Biopsy and Axillary Lymph Node Dissection for Breast Cancer Treatment Concepts - a Retrospective Study of 1,214 Breast Cancer Patients.

Stein RG, Fricker R, Rink T, Fitz H, Blasius S, Diessner J, Häusler SFM, Stüber TN, Andreas V, Wöckel A, Müller T.

Breast Care (Basel). 2017 Oct;12(5):324-328. doi: 10.1159/000477610. Epub 2017 Oct 20.

PMID:
29234253
2.

Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?

Stüber T, Novopashenny I, Diessner J, Bartmann C, Stein R, Krockenberger M, Häusler S, Janni W, Kreienberg R, Blettner M, Wöckel A, Wischnewsky M.

Oncology. 2017;92(6):317-324. doi: 10.1159/000455050. Epub 2017 Mar 24.

PMID:
28334705
3.

Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.

Diessner J, Wischnewsky M, Blettner M, Häusler S, Janni W, Kreienberg R, Stein R, Stüber T, Schwentner L, Bartmann C, Wöckel A.

PLoS One. 2016 Dec 19;11(12):e0168730. doi: 10.1371/journal.pone.0168730. eCollection 2016.

4.

Pattern of metastatic spread and subcategories of breast cancer.

Bartmann C, Wischnewsky M, Stüber T, Stein R, Krockenberger M, Häusler S, Janni W, Kreienberg R, Blettner M, Schwentner L, Wöckel A, Diessner J.

Arch Gynecol Obstet. 2017 Jan;295(1):211-223. doi: 10.1007/s00404-016-4225-4. Epub 2016 Nov 10.

PMID:
27832352
5.

Factors influencing the development of visceral metastasis of breast cancer: A retrospective multi-center study.

Bartmann C, Diessner J, Blettner M, Häusler S, Janni W, Kreienberg R, Krockenberger M, Schwentner L, Stein R, Stüber T, Wöckel A, Wischnewsky M.

Breast. 2017 Feb;31:66-75. doi: 10.1016/j.breast.2016.10.016. Epub 2016 Nov 2.

PMID:
27816834
6.

Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape.

Montalbán Del Barrio I, Penski C, Schlahsa L, Stein RG, Diessner J, Wöckel A, Dietl J, Lutz MB, Mittelbronn M, Wischhusen J, Häusler SFM.

J Immunother Cancer. 2016 Aug 16;4:49. doi: 10.1186/s40425-016-0154-9. eCollection 2016.

7.

The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients.

Stein RG, Wollschläger D, Kreienberg R, Janni W, Wischnewsky M, Diessner J, Stüber T, Bartmann C, Krockenberger M, Wischhusen J, Wöckel A, Blettner M, Schwentner L; BRENDA Study Group.

BMC Cancer. 2016 Jul 13;16:459. doi: 10.1186/s12885-016-2426-7.

8.

Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II.

Stüber T, van Ewijk R, Diessner J, Kühn T, Flock F, Felberbaum R, Blettner M, Kreienberg R, Janni W, Wöckel A, Singer S, Schwentner L.

Breast Cancer. 2017 Mar;24(2):281-287. doi: 10.1007/s12282-016-0701-8. Epub 2016 May 19.

PMID:
27193566
9.

Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.

Diessner J, Wischnewsky M, Stüber T, Stein R, Krockenberger M, Häusler S, Janni W, Kreienberg R, Blettner M, Schwentner L, Wöckel A, Bartmann C.

BMC Cancer. 2016 May 12;16:307. doi: 10.1186/s12885-016-2345-7.

10.

Guidelines are advantageous, though not essential for improved survival among breast cancer patients.

Wolters R, Wischhusen J, Stüber T, Weiss CR, Krockberger M, Bartmann C, Blettner M, Janni W, Kreienberg R, Schwentner L, Novopashenny I, Wischnewsky M, Wöckel A, Diessner J.

Breast Cancer Res Treat. 2015 Jul;152(2):357-66. doi: 10.1007/s10549-015-3484-2. Epub 2015 Jun 24.

PMID:
26105798
11.

Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study.

Diessner J, Van Ewijk R, Weiss CR, Janni W, Wischnewsky MB, Kreienberg R, Hancke K, Blettner M, Wöckel A, Schwentner L.

Arch Gynecol Obstet. 2015 Sep;292(3):655-64. doi: 10.1007/s00404-015-3691-4. Epub 2015 Mar 27.

PMID:
25814296
12.

Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1).

Diessner J, Bruttel V, Stein RG, Horn E, Häusler SF, Dietl J, Hönig A, Wischhusen J.

Cell Death Dis. 2014 Mar 27;5:e1149. doi: 10.1038/cddis.2014.115.

13.

Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion.

Häusler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Hönig A, Dietl J, Wischhusen J.

Am J Transl Res. 2014 Jan 15;6(2):129-39. eCollection 2014.

14.

Amniotic fluid insulin and C-peptide as predictive markers for fetal macrosomia, birth injuries, and delivery complications?

Stein RG, Meinusch M, Diessner J, Dietl J, Hönig A, Zollner U.

Med Sci Monit. 2014 Jan 15;20:54-8. doi: 10.12659/MSM.889503.

15.

Targeting breast cancer stem cells with HER2-specific antibodies and natural killer cells.

Diessner J, Bruttel V, Becker K, Pawlik M, Stein R, Häusler S, Dietl J, Wischhusen J, Hönig A.

Am J Cancer Res. 2013 Apr 3;3(2):211-20. Print 2013.

16.

XY gonadal dysgenesis--development of a germ cell tumor: case report.

Diessner J, Stüber T, Niederle B, Pawlik M, Dietl J, Honig A.

Eur J Gynaecol Oncol. 2013;34(6):572-4.

PMID:
24601055
17.

[Acute foeto-foetal transfusion syndrome--case report and review of the literature].

Stein RG, Diessner J, Frieauff E, Zollner U, Rehn M, Dietl J, Hönig A.

Z Geburtshilfe Neonatol. 2012 Jun;216(3):147-9. doi: 10.1055/s-0032-1309048. Epub 2012 Jun 21. Review. German.

PMID:
22825763
18.

Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells.

Engel JB, Hahne JC, Häusler SF, Meyer S, Segerer SE, Diessner J, Dietl J, Honig A.

Anticancer Res. 2012 May;32(5):2063-8.

PMID:
22593489
19.

PI3K inhibitor D-116883 is effective in in vitro models of ovarian cancer.

Honig A, Hahne JC, Meyer S, Kranke P, Häusler S, Diessner J, Dietl J, Engel JB.

Anticancer Res. 2012 May;32(5):2035-41.

PMID:
22593485
20.

[Myocardial infarction in the 34th week of gestation: case report].

Diessner J, Heuer S, Engel JB, Frambach T, Kranke P, Quaisser C, Dietl J, Honig A.

Z Geburtshilfe Neonatol. 2011 Oct;215(5):209-11. doi: 10.1055/s-0031-1271738. Epub 2011 Oct 25. German.

PMID:
22028062

Supplemental Content

Loading ...
Support Center